FrancophonIA/ELRC3.0 huggingface dataset:
English: ABILIFY 5 mg tablets ABILIFY 10 mg tablets ABILIFY 15 mg tablets ABILIFY 30 mg tablets
Icelandic: ABILIFY 10 mg munndreifitöflur ABILIFY 15 mg munndreifitöflur ABILIFY 30 mg munndreifitöflur
English: In one short-term (24-hour) placebo-controlled trial involving 291 patients with bipolar disorder presenting with agitation and disturbed behaviours, ABILIFY solution for injection was associated with statistically significant greater improvements in agitation/behavioural symptoms compared to placebo and was similar to the reference arm lorazepam.
Icelandic: Í einni skammtíma (24 klst.) samanburðarrannsókn með lyfleysu með 291 sjúklingi með geðhvarfasýki sem voru í uppnámi og sýndu hegðunartruflun kom í ljós að ABILIFY stungulyf, lausn tengdist tölfræðilega marktækt meiri bata varðandi uppnám/hegðunareinkenni samanborið við lyfleysu og var svipað lórazepam hjá viðmiðunarhópnum.
English: Tics associated with Tourette's disorder in paediatric patients (see section 4.2) The efficacy of aripiprazole was studied in paediatric subjects with Tourette's disorder (aripiprazole: n = 99, placebo: n = 44) in a randomised, double-blind, placebo-controlled, 8 week study using a fixed dose weight-based treatment group design over the dose range of 5 mg/day to 20 mg/day and a starting dose of 2 mg.
Icelandic: Tourette-röskun hjá börnum (sjá kafla 4.2) Verkun arípíprasóls var rannsökuð hjá börnum með Tourettesheilkenni (arípíprasól: n = 99, lyfleysa: n = 44) í slembiraðaðri, tvíblindri, 8 vikna rannsókn með lyfleysusamanburði þar sem notaður var fastaskammtur hjá meðferðarhópum eftir þyngd á skammtabilinu 5 mg/dag til 20 mg/dag og 2 mg upphafsskammtur.
English: ABILIFY 30 mg tablets:
Icelandic: ABILIFY 30 mg töflur:
English: ABILIFY orodispersible tablets are supplied in perforated unit dose blisters packed in cartons containing 14 × 1, 28 × 1, or 49 × 1 orodispersible tablets.
Icelandic: ABILIFY munndreifitöflur er afgreitt í rifgötuðum stakskammta álþynnum í öskjum með 14 × 1, 28 × 1 eða 49 × 1 munndreifitöflum.
English: However your doctor may prescribe a lower or higher dose to a maximum of 30 mg once a day.
Icelandic: Læknirinn getur þó ákveðið minni eða stærri skammt, að hámarki 30 mg einu sinni á sólarhring.
English: Yellow iron oxide (E 172)
Icelandic: gult járnoxíð (E 172)
English: In a clinical trial of oral aripiprazole in healthy subjects, a strong inhibitor of CYP2D6 (quinidine) increased aripiprazole AUC by 107 %, while Cmax was unchanged.
Icelandic: Í klínískri rannsókn á arípíprasóli til inntöku hjá heilbrigðum einstaklingum jók öflugur CYP2D6 hemill (kínidín) AUC aripíprazóls um 107 % meðan Cmax var óbreytt.
English: • yellowing of the skin and white part of eyes,
Icelandic: gulnun húðlitar og augnhvítu,
English: EU/1/04/276/033 (1 mg/mL, 50 mL per bottle) EU/1/04/276/034 (1 mg/mL, 150 mL per bottle) EU/1/04/276/035 (1 mg/mL, 480 mL per bottle)
Icelandic: EU/1/04/276/033 (1 mg/ml, 50 ml glas) EU/1/04/276/034 (1 mg/ml, 150 ml glas) EU/1/04/276/035 (1 mg/ml, 480 ml glas)
English: Haemodialysis
Icelandic: Munndreifitafla
English: Comparisons between aripiprazole and placebo in the proportions of patients experiencing potentially clinically significant changes in routine laboratory and lipid parameters (see section 5.1) revealed no medically important differences.
Icelandic: Enginn mikilvægur munur kom í ljós við samanburð á aripíprazóli og lyfleysu hjá sjúklingum, þar sem klínískt marktækar breytingar á niðurstöðum venjubundinna rannsókna og lípíðgilda komu í ljós (sjá kafla 5.1).
English: However, the oral solution should not be diluted with other liquids or mixed with any food prior to administration.
Icelandic: Hins vegar má hvorki blanda mixtúrunni út í aðra vökva né blanda henni út í mat.
English: Excipient with known effect 62.18 mg lactose (as monohydrate) per tablet
Icelandic: Hjálparefni með þekkta verkun 62,18 mg af mjólkursykri (sem einhýdrat) í töflu
English: • withdrawal symptoms in newborn babies in case of exposure during pregnancy,
Icelandic: fráhvarfseinkenni í nýburum ef útsetning á sér stað á meðgöngu,
English: The efficacy of ABILIFY solution for injection in patients with agitation and disturbed behaviours has not been established related to conditions other than schizophrenia and manic episodes in Bipolar I Disorder.
Icelandic: Verkun ABILIFY stungulyfs hjá sjúklingum sem eru í uppnámi og með hegðunartruflun hefur ekki verið metin nema í tengslum við geðklofa og oflæti hjá sjúklingum með geðhvarfasýki I.
English: When the CYP3A4 inducer is withdrawn from the combination therapy, the aripiprazole dose should then be reduced to the recommended dose (see section 4.5).
Icelandic: CYP3A4 virkja í samsettri meðferð með aripíprazóli er hætt á að minnka skammta aripíprazóls í ráðlagða skammta (sjá kafla 4.5).
English: In a clinical trial of oral aripiprazole in healthy subjects, a strong inhibitor of CYP3A4 (ketoconazole) increased aripiprazole AUC and Cmax by 63 % and 37 %, respectively.
Icelandic: Í klínískri rannsókn á arípíprasóli til inntöku hjá heilbrigðum einstaklingum jók öflugur CYP3A4 hemill (ketókónazól) AUC aripíprazóls um 63 % og Cmax um 37 %.
English: • muscle stiffness, and drowsiness or sleepiness, slower breathing, choking, high or low blood pressure, abnormal rhythms of the heart.
Icelandic: vöðvastífni og svefnhöfgi eða syfja; hægari öndun, köfnunartilfinning, hár eða lágur blóðþrýstingur, óeðlilegur hjartsláttartaktur.
English: 14 × 1 orodispersible tablets 28 × 1 orodispersible tablets 49 × 1 orodispersible tablets
Icelandic: 14 × 1 munndreifitafla 28 × 1 munndreifitafla 49 × 1 munndreifitafla
English: ABILIFY tablets are supplied in perforated unit dose blisters packed in cartons containing 14 × 1, 28 × 1, 49 × 1, 56 × 1, or 98 × 1 tablets.
Icelandic: ABILIFY töflur fást í rifgötuðum stakskammta álþynnum í öskjum með 14 × 1, 28 × 1, 49 × 1, 56 × 1 eða 98 × 1 töflum.
English: Red iron oxide (E 172)
Icelandic: rautt járnoxíð (E 172)
English: In three short-term (4 to 6 weeks) placebo-controlled trials involving 1,228 schizophrenic adult patients, presenting with positive or negative symptoms, oral aripiprazole was associated with statistically significantly greater improvements in psychotic symptoms compared to placebo.
Icelandic: Í þremur stuttum (4 til 6 vikna) samanburðarrannsóknum með lyfleysu á 1.228 fullorðnum sjúklingum með geðklofa, með jákvæð eða neikvæð einkenni, kom í ljós að aripíprazól var tölfræðilega marktækt, tengt meiri bata en lyfleysa.
English: ABILIFY 30 mg tablets
Icelandic: ABILIFY 30 mg töflur
English: There is no effect of a high fat meal on the pharmacokinetics of aripiprazole.
Icelandic: Fiturík fæða hefur ekki áhrif á lyfjahvörf aripíprazóls.
English: Each vial contains 9.75 mg aripiprazole.
Icelandic: Hvert hettuglas inniheldur 9,75 mg aripíprazól.
English: Other medicines and ABILIFY
Icelandic: Notkun annarra lyfja samhliða ABILIFY
English: • rapid heartbeat, agitation/aggressiveness, problems with speech.
Icelandic: • hröðum hjartslætti, óróleika/árásargirni, talörðugleikum.
English: Package leaflet: Information for the user ABILIFY 7.5 mg/mL solution for injection aripiprazole
Icelandic: Upplýsingar fyrir notanda lyfsins ABILIFY 7,5 mg/ml stungulyf, lausn aripíprazól
English: When weak inhibitors of CYP3A4 (e.g. diltiazem) or CYP2D6 (e.g. escitalopram) are used concomitantly with aripiprazole, modest increases in plasma aripiprazole concentrations may be expected.
Icelandic: Þegar vægir CYP3A4 (t.d. diltíazem) eða CYP2D6 (t.d. escítalopram) hemlar eru notaðir samtímis ABILIFY má búast við lítilsháttar aukningu á þéttni aripíprazóls í blóðvökva.
English: ABILIFY 10 mg tablets are rectangular and pink, marked with ‘A-008' and ‘10' on one side.
Icelandic: ABILIFY 10 mg töflur eru rétthyrndar og bleikar merktar með ‘A-008' og ‘10' á annarri hliðinni.
English: ABILIFY 5 mg tablets:
Icelandic: ABILIFY 5 mg töflur:
English: • difficulty swallowing,
Icelandic: • gegndarlaus svitamyndun,
English: Aluminium perforated unit dose blisters in cartons of 14 × 1, 28 × 1, 49 × 1, 56 × 1, 98 × 1 tablets.
Icelandic: Rifgataðar stakskammta álþynnur í öskjum með 14 × 1, 28 × 1, 49 × 1, 56 × 1, 98 × 1 töflum.
English: ABILIFY 10 mg tablets:
Icelandic: ABILIFY 10 mg töflur:
English: In a long-term 26-week placebo-controlled trial, the incidence of EPS was 19 % for aripiprazole-treated patients and 13.1 % for placebo-treated patients.
Icelandic: Í langtíma samanburðarrannsókn með lyfleysu sem stóð í 26 vikur, var tíðni utanstrýtuheilkenna 19 % hjá sjúklingum sem fengu aripíprazól samanborið við 13,1 % hjá sjúklingum sem fengu lyfleysu.
English: ABILIFY 7.5 mg/mL solution for injection
Icelandic: ABILIFY 7,5 mg/ml stungulyf, lausn
English: ABILIFY orodispersible tablets contain aspartame.
Icelandic: ABILIFY munndreifitöflur innihalda aspartam.
English: If you stop taking ABILIFY
Icelandic: Ef hætt er að taka ABILIFY
English: Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Icelandic: Ræða skal við lækninn hvernig best sé að næra barnið þegar ABILIFY er tekið.
English: Excipient with known effect 57 mg lactose (as monohydrate) per tablet
Icelandic: Hjálparefni með þekkta verkun 57 mg af mjólkursykri (sem einhýdrat) í töflu
English: Excipient with known effect 67 mg lactose (as monohydrate) per tablet
Icelandic: Hjálparefni með þekkta verkun 67 mg af mjólkursykri (sem einhýdrat) í töflu
English: Rectangular and pink, engraved with "A-008" and "10" on one side.
Icelandic: Rétthyrnd og bleik, merkt með „A-008“ og „10“ á annarri hliðinni.
English: Diastolic blood pressure increased
Icelandic: Blóðsykurhækkun
English: Lactose monohydrate Maize starch
Icelandic: Mjólkursykureinhýdrat Maíssterkja
English: Tablet disintegration occurs rapidly in saliva.
Icelandic: Taflan sundrast hratt í munnvatni.
English: Tablets
Icelandic: Lyfjagjöf
English: ABILIFY 10 mg tablets
Icelandic: ABILIFY 10 mg töflur
English: Microcrystalline cellulose Hydroxypropyl cellulose Magnesium stearate
Icelandic: Örkristallaður sellulósi Hýdroxýprópýlsellulósi Magnesíumsterat
English: In two long-term trials with adolescent (13 to 17 years) schizophrenia and bipolar patients treated with aripiprazole, incidence of low serum prolactin levels in females (< 3 ng/mL) and males (< 2 ng/mL) was 37.0 % and 59.4 %, respectively.
Icelandic: Í tveimur langtímarannsóknum á unglingum (13 til 17 ára) með geðklofa og geðhvarfasýki, sem fengu aripíprazól, var tíðni lágs prólaktíns í sermi hjá stúlkum (< 3 ng/ml) 37,0 % og drengjum (< 2 ng/ml)
English: ABILIFY contains fructose and sucrose
Icelandic: ABILIFY inniheldur frúktósa og súkrósa
English: Aripiprazole is widely distributed throughout the body with an apparent volume of distribution of 4.9 L/kg, indicating extensive extravascular distribution.
Icelandic: Aripíprazól dreifist um líkamann með sýnilegu dreifingarrúmmáli sem er 4,9 1/kg sem bendir til víðtækrar dreifingar utan æða (extravascular) dreifingar.
English: ABILIFY 15 mg tablets:
Icelandic: ABILIFY 15 mg töflur:
English: ABILIFY 1 mg/mL oral solution aripiprazole
Icelandic: ABILIFY 1 mg/ml mixtúra, lausn. aripíprazól
English: In the pooled adolescent schizophrenia population (13 to 17 years) with exposure up to 2 years, incidence of low serum prolactin levels in females (< 3 ng/mL) and males (< 2 ng/mL) was 29.5 % and 48.3 %, respectively.
Icelandic: Hjá heildarþýði sjúklinga með geðklofa (13 til 17 ára) eftir útsetningu í allt að 2 ár var tíðni lágra prólaktíngilda í sermi 29,5 % hjá stúlkum (< 3 ng/ml) og 48,3 % hjá drengjum (< 2 ng/ml).
English: However, you should not dilute with other liquids or mix with other food prior to taking ABILIFY oral solution.
Icelandic: Hins vegar má hvorki blanda ABILIFY mixtúru út í aðra vökva né blanda henni út í mat.
English: If you stop receiving ABILIFY
Icelandic: Ef hætt er að gefa ABILIFY
English: Upon discontinuation of strong CYP3A4 inducers, the dosage of aripiprazole should be reduced to the recommended dose.
Icelandic: Þegar notkun öflugra CYP3A4 virkja er hætt á að minnka skammta aripíprazól að ráðlögðum skammti.
English: However, in a single-dose, intramuscular study of aripiprazole (dose 15 mg) in healthy subjects, administered simultaneously with intramuscular lorazepam (dose 2 mg), the intensity of sedation was greater with the combination as compared to that observed with aripiprazole alone.
Icelandic: Í einskammta rannsókn á heilbrigðum einstaklingum með aripíprazól í vöðva (15 mg skammtur) sem var gefið samtímis lórazepami (2 mg skammtur) kom þó í ljós að slæving var meiri við þessa samsetningu en þegar aripíprazól var gefið eitt og sér.
English: • tiredness,
Icelandic: • skjálfti,
English: Aripiprazole/metabolites are excreted in human milk.
Icelandic: Aripíprazól/umbrotsefni skilst út í brjóstamjólk.
English: Aripiprazole is well absorbed, with peak plasma concentrations occurring within 3 to 5 hours after dosing.
Icelandic: Aripíprazól frásogast vel og hámarksblóðþéttni næst innan 3 til 5 klst. eftir gjöf.
English: ABILIFY 15 mg orodispersible tablets are round and yellow, marked with ‘"A" over "641"' on one side and ‘15' on the other.
Icelandic: ABILIFY 15 mg munndreifitöflur eru kringlóttar og gular, merktar með ‘„A“ yfir „641“' á annarri hliðinni og ‘15' á hinni.
English: The dose of ABILIFY must be measured using the calibrated cup or the 2 mL calibrated dropping pipette supplied in the carton.
Icelandic: Skammt ABILIFY á að mæla með meðfylgjandi mæliglasi eða 2 ml dropateljara með kvarða.
English: A vial provides 9.75 mg in 1.3 mL.
Icelandic: Í hverju hettuglasi eru 9,75 mg í 1,3 ml.
English: Oesophageal dysmotility and aspiration have been associated with the use of antipsychotics, including aripiprazole.
Icelandic: Hreyfingarörðugleikar í vélinda og ásvelging hafa verið tengd notkun geðrofslyfja, m.a. aripíprazól.
English: In clinical trials, uncommon cases of seizure were reported during treatment with aripiprazole.
Icelandic: Í klínískum rannsóknum var sjaldan greint frá krömpum í tengslum við meðferð með aripíprazóli.
English: • stiffness,
Icelandic: • stirðleiki,
English: ABILIFY 15 mg orodispersible tablets 15 mg: Round and yellow, marked with "A" over "641" on one side and "15" on the other.
Icelandic: ABILIFY 15 mg munndreifitöflur Kringlótt og gul, merkt „A“ yfir „641“ á annarri hliðinni og „15“ á hinni.
English: Blood glucose fluctuation Creatine phosphokinase increased
Icelandic: Sveiflur í glúkósaþéttni í blóði Aukning á kreatínkínasa
English: ABILIFY 5 mg tablets
Icelandic: ABILIFY 5 mg töflur
English: Hepatitis Jaundice
Icelandic: Aukin dánartíðni
English: Oral solution Clear, colourless to light yellow liquid solution.
Icelandic: Mixtúra, lausn Tær, litlaus/lítið eitt gulleit lausn.
English: In a 52-week, placebo-controlled trial, in patients with a current manic or mixed episode of Bipolar I Disorder who achieved sustained remission (Young Mania Rating Scale [YMRS] and MADRS with total scores ≤ 12) on aripiprazole (10 mg/day to 30 mg/day) adjunctive to lithium or valproate for 12 consecutive weeks, adjunctive aripiprazole demonstrated superiority over placebo with a 46 % decreased risk (hazard ratio of 0.54) in preventing bipolar recurrence and a 65 % decreased risk (hazard ratio of 0.35) in preventing recurrence into mania over adjunctive placebo but failed to demonstrate superiority over placebo in preventing recurrence into depression.
Icelandic: 46 % minni líkur (áhættuhlutfall 0,54) á endurkomu geðhvarfa og 65 % minni líkur (áhættuhlutfall 0,35) á endurkomu oflætis miðað við viðbót með lyfleysu, en var ekki fremra lyfleysu í að fyrirbyggja endurkomu þunglyndis.
English: ABILIFY 15 mg tablets
Icelandic: ABILIFY 15 mg töflur
English: Venous thromboembolism (including pulmonary embolism and deep vein thrombosis)
Icelandic: Bláæðasegarek (þar með talið lungnasegarek og segamyndun í djúplægum bláæðum)
English: • agitation,
Icelandic: • uppköst,
English: Package leaflet: Information for the user ABILIFY 1 mg/mL oral solution aripiprazole
Icelandic: Upplýsingar fyrir notanda lyfsins ABILIFY 1 mg/ml mixtúra, lausn aripíprazól
English: • antidepressants or herbal remedy used to treat depression and anxiety (such as fluoxetine,
Icelandic: þunglyndislyf eða náttúrulyf sem notuð eru til að meðhöndla þunglyndi og kvíða (svo sem flúoxetín, paroxetín, jóhannesarjurt)
English: • uncontrollable twitching, jerking or writhing movements, restless legs,
Icelandic: • óviðráðanlegir snúningar, kippir eða sársaukafullt ið, fótaóeirð,
English: • hiccups,
Icelandic: hiksti,
English: ABILIFY 7.5 mg/mL solution for injection aripiprazole
Icelandic: ABILIFY 7,5 mg/ml stungulyf, lausn aripíprazól
English: Aripiprazole is well absorbed when administered orally as the solution.
Icelandic: Aripíprazol frásogast vel þegar það er gefið um munn sem mixtúra, lausn.
English: Cardiovascular disorders
Icelandic: Vöðvaspennutruflun
English: Tardive dyskinesia
Icelandic: Önnur utanstrýtueinkenni
English: Therefore cardiovascular monitoring should be started immediately and should include continuous electrocardiographic monitoring to detect possible arrhythmias.
Icelandic: Því þarf strax að fylgjast vel með starfsemi hjarta- og æðakerfis, m.a. fylgjast með hjartarafriti vegna hugsanlegra hjartsláttartruflana.
English: ABILIFY 1 mg/mL oral solution
Icelandic: ABILIFY 1 mg/ml mixtúra, lausn
English: ABILIFY 30 mg orodispersible tablets are round and pink, marked with ‘"A" over "643"' on one side and ‘30' on the other.
Icelandic: ABILIFY 30 mg munndreifitöflur eru kringlóttar og bleikar, merktar með ‘„A“ yfir „643“' á annarri hliðinni og ‘30' á hinni.
English: ABILIFY 10 mg orodispersible tablets are round and pink, marked with ‘"A" over "640"' on one side and ‘10' on the other.
Icelandic: ABILIFY 10 mg munndreifitöflur eru kringlóttar og bleikar, merktar með ‘„A“ yfir „640“' á annarri hliðinni og ‘10' á hinni.
English: EU/1/04/276/016 (30 mg, 14 × 1 tablets) EU/1/04/276/017 (30 mg, 28 × 1 tablets) EU/1/04/276/018 (30 mg, 49 × 1 tablets) EU/1/04/276/019 (30 mg, 56 × 1 tablets) EU/1/04/276/020 (30 mg, 98 × 1 tablets)
Icelandic: EU/1/04/276/016 (30 mg, 14 × 1 tafla) EU/1/04/276/017 (30 mg, 28 × 1 tafla) EU/1/04/276/018 (30 mg, 49 × 1 tafla) EU/1/04/276/019 (30 mg, 56 × 1 tafla) EU/1/04/276/020 (30 mg, 98 × 1 tafla)
English: EU/1/04/276/030 (30 mg, 14 × 1 orodispersible tablets) EU/1/04/276/031 (30 mg, 28 × 1 orodispersible tablets) EU/1/04/276/032 (30 mg, 49 × 1 orodispersible tablets)
Icelandic: EU/1/04/276/030 (30 mg, 14 × 1 munndreifitafla) EU/1/04/276/031 (30 mg, 28 × 1 munndreifitafla) EU/1/04/276/032 (30 mg, 49 × 1 munndreifitafla)
English: • feeling anxious,
Icelandic: • kvíðatilfinning,
English: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicinal product.
Icelandic: Sjúklingar með arfgengt frúktósaóþol, glúkósa-galaktósa vanfrásog eða súkrasaísómaltasaþurrð, sem er mjög sjaldgæft, skulu ekki taka lyfið.
English: The safety profile of a long-term, double-blind, placebo-controlled trial was also similar except for the following reactions that were reported more frequently than paediatric patients taking placebo: weight decreased, blood insulin increased, arrhythmia, and leukopenia were reported commonly (≥ 1/100,
Icelandic: Niðurstöður varðandi öryggi í langvarandi, tvíblindri samanburðarrannsókn með lyfleysu voru einnig svipaðar nema oftar var greint frá eftirtöldum aukaverkunum en hjá börnum sem fengu lyfleysu:
English: Each tablet contains 5 mg of aripiprazole.
Icelandic: Hver tafla inniheldur 5 mg af aripíprazól.
English: However, in a single-dose, intramuscular study of aripiprazole (dose 15 mg) in healthy subjects, administered simultaneously with intramuscular lorazepam (dose 2 mg), the orthostatic hypotension observed was greater with the combination as compared to that observed with lorazepam alone.
Icelandic: Í einskammta rannsókn á heilbrigðum einstaklingum með aripíprazól í vöðva (15 mg skammtur) sem var gefið samtímis lórazepami (2 mg skammtur) kom í ljós að réttstöðuþrýstingsfall var meira þegar þessi samsetning var gefin en þegar lórazepam var gefið eitt og sér.
English: ABILIFY 30 mg orodispersible tablets aripiprazole
Icelandic: ABILIFY 30 mg munndreifitöflur aripíprazól
English: • The other ingredients are lactose monohydrate, maize starch, microcrystalline cellulose, hydroxypropylcellulose and magnesium stearate.
Icelandic: Önnur innihaldsefni eru mjólkursykureinhýdrat, maíssterkja, örkristallaður sellulósi, hýdroxýprópýlsellulósi, magnesíumsterat.
English: ABILIFY 5 mg tablets aripiprazole
Icelandic: ABILIFY 5 mg töflur aripíprazól
English: Aripiprazole exhibited antagonist properties in animal models of dopaminergic hyperactivity and agonist properties in animal models of dopaminergic hypoactivity.
Icelandic: dýralíkönum með dópamínofvirkni hefur aripíprazól hamlandi eiginleika og í dýralíkönum með dópamínvanvirkni hefur aripíprazól eiginleika viðtakaörva.
English: ABILIFY 30 mg orodispersible tablets 30 mg: Round and pink, marked with "A" over "643" on one side and "30" on the other.
Icelandic: ABILIFY 30 mg munndreifitöflur Kringlótt og bleik, merkt „A“ yfir „643“ á annarri hliðinni og „30“ á hinni.
English: EU/1/04/276/011 (15 mg, 14 × 1 tablets) EU/1/04/276/012 (15 mg, 28 × 1 tablets) EU/1/04/276/013 (15 mg, 49 × 1 tablets) EU/1/04/276/014 (15 mg, 56 × 1 tablets) EU/1/04/276/015 (15 mg, 98 × 1 tablets)
Icelandic: EU/1/04/276/011 (15 mg, 14 × 1 tafla) EU/1/04/276/012 (15 mg, 28 × 1 tafla) EU/1/04/276/013 (15 mg, 49 × 1 tafla) EU/1/04/276/014 (15 mg, 56 × 1 tafla) EU/1/04/276/015 (15 mg, 98 × 1 tafla)
English: ABILIFY 30 mg orodispersible tablets Red iron oxide (E 172)
Icelandic: ABILIFY 10 mg munndreifitöflur: rautt járnoxíð (E 172) ABILIFY 15 mg munndreifitöflur: gult járnoxíð (E 172) ABILIFY 30 mg munndreifitöflur: rautt járnoxíð (E 172)
English: EU/1/04/276/006 (10 mg, 14 × 1 tablets) EU/1/04/276/007 (10 mg, 28 × 1 tablets) EU/1/04/276/008 (10 mg, 49 × 1 tablets) EU/1/04/276/009 (10 mg, 56 × 1 tablets) EU/1/04/276/010 (10 mg, 98 × 1 tablets)
Icelandic: EU/1/04/276/006 (10 mg, 14 × 1 tafla) EU/1/04/276/007 (10 mg, 28 × 1 tafla) EU/1/04/276/008 (10 mg, 49 × 1 tafla) EU/1/04/276/009 (10 mg, 56 × 1 tafla) EU/1/04/276/010 (10 mg, 98 × 1 tafla)
English: Each tablet contains 30 mg of aripiprazole.
Icelandic: Hver tafla inniheldur 30 mg aripíprazól.
English: Diarrhoea
Icelandic: Akatísía
English: ABILIFY 10 mg tablets aripiprazole
Icelandic: ABILIFY 10 mg töflur aripíprazól
English: Each tablet contains 15 mg of aripiprazole.
Icelandic: Hver tafla inniheldur 15 mg af aripíprazól.
English: Temperature regulation disorder (e.g. hypothermia, pyrexia) Chest pain
Icelandic: Röskun á hitastillingu (t.d. lágur líkamshiti, hitahækkun) Brjóstverkur
English: No dosage adjustment is required for patients with mild to moderate hepatic impairment.
Icelandic: Ekki eru til nægjanleg gögn til að gefa ráðleggingar varðandi skammta hjá sjúklingum með alvarlega skerta lifrarstarfsemi.
English: ABILIFY 10 mg orodispersible tablets 10 mg: Round and pink, marked with "A" over "640" on one side and "10" on the other.
Icelandic: ABILIFY 10 mg munndreifitöflur Kringlótt og bleik, merkt „A“ yfir „640“ á annarri hliðinni og „10“ á hinni.
English: ABILIFY 30 mg tablets aripiprazole
Icelandic: ABILIFY 30 mg töflur aripíprazól
English: EU/1/04/276/001 (5 mg, 14 × 1 tablets) EU/1/04/276/002 (5 mg, 28 × 1 tablets) EU/1/04/276/003 (5 mg, 49 × 1 tablets) EU/1/04/276/004 (5 mg, 56 × 1 tablets) EU/1/04/276/005 (5 mg, 98 × 1 tablets)
Icelandic: EU/1/04/276/001 (5 mg, 14 × 1 tafla) EU/1/04/276/002 (5 mg, 28 × 1 tafla) EU/1/04/276/003 (5 mg, 49 × 1 tafla) EU/1/04/276/004 (5 mg, 56 × 1 tafla) EU/1/04/276/005 (5 mg, 98 × 1 tafla)
English: In clinical trials aripiprazole has not been shown to induce clinically relevant weight gain.
Icelandic: Klínískar rannsóknir hafa ekki sýnt fram á þyngdaraukningu af völdum aripíprazóls til inntöku, sem skipta máli klínískt.
English: Each tablet contains 10 mg of aripiprazole.
Icelandic: Hver tafla inniheldur 10 mg af aripíprazól.
English: ABILIFY 30 mg orodispersible tablets: This medicine contains 6 mg aspartame in each tablet.
Icelandic: Lyfið inniheldur 6 mg af aspartam í hverri töflu.